[Retracted] Protumor Effects of Histone H3–H4 Chaperone Antisilencing Feature 1B Gene on Lung Adenocarcinoma: In Silico and In Vitro Analyses

Figure 2

Prognostic value of ASF1B in TCGA pan-cancer and LUAD data. (a, b) Correlation between OS, RFS, and ASF1B mRNA expression in TCGA pan-cancer data. (c, d) Association between ASF1B gene expression and prognostic outcomes (overall survival (OS) and relapse-free survival (RFS)) of LUAD patients. The association between tumor characteristic variables ((e) N stage, (f) pathologic stage, (g) primary therapy outcome, and (h) Number_pack_years_smoked) and the expression level of ASF1B in LUAD. (h, i) Forest plot depicting results of univariate and multivariate analyses for OS as survival outcome.

(a) ASF1B-OS-pan-cancer

(b) ASF1B-RFS-pan-cancer

(c) ASF1B-OS-LUAD

(d) ASF1B-RFS-LUAD

(e) N stage

(f) Pathologic stage

(g) Primary therapy outcome

(h) Number_pack_years_smoked

(i) Forest plot-univariate analysis

(j) Forest plot-multivariate analysis